BRKVX
Price
$14.60
Change
-$0.15 (-1.02%)
Updated
Nov 8 closing price
VEMAX
Price
$39.12
Change
-$0.67 (-1.68%)
Updated
Nov 8 closing price
Ad is loading...

BRKVX vs VEMAX

Header iconBRKVX vs VEMAX Comparison
Open Charts BRKVX vs VEMAXBanner chart's image
MFS Blended Research Em Mkts Eq R6
Price$14.60
Change-$0.15 (-1.02%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx Adm
Price$39.12
Change-$0.67 (-1.68%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BRKVX vs VEMAX Comparison Chart
Loading...
VS
BRKVX vs. VEMAX commentary
Nov 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKVX is a StrongSell and VEMAX is a Sell.

FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 113B vs. BRKVX (91.5M). VEMAX pays higher dividends than BRKVX: VEMAX (3.43) vs BRKVX (2.69). BRKVX was incepted earlier than VEMAX: BRKVX (9 years) vs VEMAX (18 years). BRKVX is a more actively managed with annual turnover of: 63.00 vs. VEMAX (5.00). BRKVX has a lower initial minimum investment than VEMAX: BRKVX (0) vs VEMAX (3000). BRKVX annual gain was more profitable for investors over the last year : 25.49 vs. VEMAX (22.46). BRKVX return over 5 years is better than : 21.44 vs. VEMAX (20.01).
BRKVXVEMAXBRKVX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years18 years-
Gain YTD17.55215.063117%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets91.5M113B0%
Annual Yield % from dividends2.693.4379%
Returns for 1 year25.4922.46113%
Returns for 3 years-1.02-2.1847%
Returns for 5 years21.4420.01107%
Returns for 10 yearsN/A32.08-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRAD15.861.55
+10.83%
Sportradar Group AG
MBOT1.020.08
+8.15%
Microbot Medical
TPB51.692.09
+4.21%
Turning Point Brands
STXS1.870.03
+1.63%
Stereotaxis
MKL1650.7414.60
+0.89%
Markel Group